Research Article

Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan

Table 2

Odds ratio (OR) and 95% confidence interval (CI) of CAD patients associated with genotyping frequencies of CCL5-403 and CCR5-59029.

VariableNon-CAD () (%)CAD () (%)OR (95% CI) value

CCL5-403
 CC85 (52.8%)148 (46.0%)1.00
 CT70 (43.5%)142 (44.1%)1.165 (0.788–1.723) 0.444
 TT 6 (3.7%)32 (9.9%)3.063 (1.231–7.624)0.012
 CC85 (52.8%)148 (46.0%)1.00
 CT or TT76 (47.2%)174 (54.0%)1.315 (0.900–1.921)0.157
 C240 (74.5%)438 (68.0%)1.00
 T82 (25.5%)206 (32.0%)1.377 (1.019–1.859)
CCR5-59029
 GG67 (41.6%)132 (41.0%)1.00
 GA71 (44.1%)146 (45.3%)1.044 (0.694–1.570)0.837
 AA23 (14.3%)44 (13.7%)0.971 (0.542–1.741)0.921
 GG67 (41.6%)132 (41.0%)1.00
 GA or AA94 (58.4%)190 (59.0%)1.026 (0.699–1.506)0.896
 G205 (63.7%)410 (63.7%)1.00
 A117 (36.3%)134 (36.3%)1.000 (0.757–1.321)1.000

The odds ratio (OR) with their 95% confidence intervals were estimated by logistic regression.
Significance value < 0.05.